Thu, December 14, 2017
Wed, December 13, 2017
Tue, December 12, 2017

Jason McCarthy Downgraded (BLUE) to Hold on, Dec 13th, 2017

Jason McCarthy of Maxim Group, Downgraded "bluebird bio, Inc." (BLUE) to Hold on, Dec 13th, 2017.

Jason has made no other calls on BLUE in the last 4 months.



There are 7 other peers that have a rating on BLUE. Out of the 7 peers that are also analyzing BLUE, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017


These are the ratings of the 5 analyists that currently disagree with Jason


  • Biren Amin of "Jefferies" Upgraded from Hold to Strong Buy on, Monday, December 11th, 2017
  • John Newman of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $202 on, Tuesday, December 5th, 2017
  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017